Evaluation of the Prognostic Value of the Mayo Additive Staging System and Minimal Residual Disease in Newly Diagnosed Multiple Myeloma Patients

ABSTRACT Introduction This study aimed to evaluate the prognostic value of the Mayo additive staging system (MASS) and minimal residual disease (MRD) in newly diagnosed multiple myeloma (NDMM) patients. Methods A total of 238 NDMM patients were enrolled in Beijing Chaoyang Hospital. Fluorescence in‐...

Full description

Bibliographic Details

Published in:	Cancer Medicine
Main Authors:	Yichuan Song, Rui Zhao, Wenxuan Fu, Jing Zhao, Qingtao Wang, Rui Zhang
Format:	Article
Language:	English
Published:	Wiley 2024-11-01
Subjects:	Mayo additive staging system minimal residual disease multiple myeloma prognosis response to treatment
Online Access:	https://doi.org/10.1002/cam4.70382